158 related articles for article (PubMed ID: 2545182)
1. Modulation of gentamicin nephrotoxicity by chronic inhibition of angiotensin-I-converting enzyme in rat.
Morin JP; Thomas N; Toutain H; Borghi H; Fillastre JP
Arch Toxicol; 1989; 63(1):47-53. PubMed ID: 2545182
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with an angiotensin converting enzyme inhibitor may increase the nephrotoxicity of gentamicin in rats].
Morin JP; Thomas N; Toutain H; Borghi H; Fillastre JP
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):652-6. PubMed ID: 2797891
[TBL] [Abstract][Full Text] [Related]
3. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
4. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Tokita Y; Franco-Saenz R; Mulrow PJ
Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
[TBL] [Abstract][Full Text] [Related]
5. Acute but not chronic angiotensin-converting enzyme inhibition induces enzyme synthesis in the glomerulus of the spontaneously hypertensive rat.
Hodge G; Makarious MM; Charlesworth JA; Duggan KA
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):460-2. PubMed ID: 9171960
[TBL] [Abstract][Full Text] [Related]
6. Renal amylin binding in normotensive and hypertensive rats: effects of angiotensin converting enzyme inhibition with perindopril.
Cao Z; Wookey PJ; Wu LL; Voskuil M; van Geenen RC; Cooper ME
J Hypertens; 1997 Nov; 15(11):1245-52. PubMed ID: 9383173
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity.
Mendelsohn FA; Pupic V; Jackson B; Cubela R; Johnston CI
Am J Hypertens; 1991 Mar; 4(3 Pt 2):220S-225S. PubMed ID: 1645981
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
[TBL] [Abstract][Full Text] [Related]
9. Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat.
Ramsammy LS; Josepovitz C; Ling KY; Lane BP; Kaloyanides GJ
Biochem Pharmacol; 1987 Jul; 36(13):2125-32. PubMed ID: 3111476
[TBL] [Abstract][Full Text] [Related]
10. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
Jackson B; Cubela RB; Johnston CI
J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236
[TBL] [Abstract][Full Text] [Related]
11. Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography.
Sakaguchi K; Jackson B; Chai SY; Mendelsohn FA; Johnson CI
J Cardiovasc Pharmacol; 1988 Dec; 12(6):710-7. PubMed ID: 2467090
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement.
Jackson B; Cubela RB; Johnston CI
J Pharmacol Exp Ther; 1988 Jun; 245(3):950-5. PubMed ID: 2838609
[TBL] [Abstract][Full Text] [Related]
13. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
[TBL] [Abstract][Full Text] [Related]
14. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
Lantelme P; Lo M; Luttenauer L; Sassard J
Am J Physiol; 1997 Nov; 273(5):R1793-9. PubMed ID: 9374825
[TBL] [Abstract][Full Text] [Related]
15. Inability of nitrendipine to protect against gentamicin nephrotoxicity in the rat.
Kacew S
Biomed Environ Sci; 1989 Jun; 2(2):160-6. PubMed ID: 2556158
[TBL] [Abstract][Full Text] [Related]
16. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell DJ; Kladis A; Duncan AM
Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
[TBL] [Abstract][Full Text] [Related]
17. Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: effects of heart failure and angiotensin-converting enzyme inhibitor treatment.
Kelly MP; Kahr O; Aalkjaer C; Cumin F; Samani NJ
Clin Sci (Lond); 1997 May; 92(5):455-65. PubMed ID: 9176018
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
Zhuo J; Casley D; Murone C; Mendelsohn FA
J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, restores the lower limit of autoregulation of cerebral blood flow in the awake renovascular hypertensive rat.
Muller F; Lartaud I; Bray L; Atkinson J; Janian P; Burlet C; Capdeville C
J Hypertens; 1990 Nov; 8(11):1037-42. PubMed ID: 1963186
[TBL] [Abstract][Full Text] [Related]
20. Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril.
Jackson B; Cubela RB; Sakaguchi K; Johnston CI
Endocrinology; 1988 Jul; 123(1):50-5. PubMed ID: 2838262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
